ACAD
36.55
+0.49
+1.36%
AEMD
6.26
+0.14
+2.2892%
APRI
0.334
-0.006
-1.7378%
ARNA
1.68
-0.1
-5.62%
ATEC
0.39
+0.03
+8.33%
CNAT
2.2
+0.01
+0.46%
CRXM
0.18
0.00
0.00%
CYTX
2.03
-0.02
-0.98%
DXCM
87.89
+3.26
+3.85%
GNMK
9.8
+0.25
+2.62%
HALO
9.24
-0.11
-1.18%
ILMN
150.76
-0.55
-0.36%
INNV
0.44
+0.04
+9.73%
INO
9.13
+0.08
+0.88%
ISCO
1.945
0.00
0.00%
ISIS
57.56
0.00
0.00%
LGND
132.55
+0.59
+0.45%
LPTN
2.1
+0.19
+9.95%
MBVX
0.675
+0.045
+7.143%
MEIP
1.37
-0.02
-1.44%
MNOV
6.48
-0.2
-2.99%
MRTX
5.08
-0.01
-0.20%
MSTX
0.439
+0.028
+6.709%
NBIX
49.51
+0.43
+0.88%
NUVA
61.54
-0.37
-0.60%
ONCS
1.74
+0.04
+2.35%
ONVO
4.06
+0.04
+1.00%
OREX
3.51
0.00
0.00%
OTIC
14.8
+0.13
+0.89%
QDEL
19.54
-0.09
-0.46%
RCPT
231.96
0.00
0.00%
RGLS
3.43
+0.01
+0.29%
RMD
65.93
+0.04
+0.06%
SCIE
0.004
0.00
-5.1282%
SPHS
4.38
+0.42
+10.61%
SRNE
6.3
0.00
0.00%
TROV
5.04
-0.04
-0.79%
VICL
4.03
-0.35
-7.99%
VOLC
18
0.00
0.00%
ZGNX
8.62
-0.04
-0.46%
ACAD
36.55
+0.49
+1.36%
AEMD
6.26
+0.14
+2.2892%
APRI
0.334
-0.006
-1.7378%
ARNA
1.68
-0.1
-5.62%
ATEC
0.39
+0.03
+8.33%
CNAT
2.2
+0.01
+0.46%
CRXM
0.18
0.00
0.00%
CYTX
2.03
-0.02
-0.98%
DXCM
87.89
+3.26
+3.85%
GNMK
9.8
+0.25
+2.62%
HALO
9.24
-0.11
-1.18%
ILMN
150.76
-0.55
-0.36%
INNV
0.44
+0.04
+9.73%
INO
9.13
+0.08
+0.88%
ISCO
1.945
0.00
0.00%
ISIS
57.56
0.00
0.00%
LGND
132.55
+0.59
+0.45%
LPTN
2.1
+0.19
+9.95%
MBVX
0.675
+0.045
+7.143%
MEIP
1.37
-0.02
-1.44%
MNOV
6.48
-0.2
-2.99%
MRTX
5.08
-0.01
-0.20%
MSTX
0.439
+0.028
+6.709%
NBIX
49.51
+0.43
+0.88%
NUVA
61.54
-0.37
-0.60%
ONCS
1.74
+0.04
+2.35%
ONVO
4.06
+0.04
+1.00%
OREX
3.51
0.00
0.00%
OTIC
14.8
+0.13
+0.89%
QDEL
19.54
-0.09
-0.46%
RCPT
231.96
0.00
0.00%
RGLS
3.43
+0.01
+0.29%
RMD
65.93
+0.04
+0.06%
SCIE
0.004
0.00
-5.1282%
SPHS
4.38
+0.42
+10.61%
SRNE
6.3
0.00
0.00%
TROV
5.04
-0.04
-0.79%
VICL
4.03
-0.35
-7.99%
VOLC
18
0.00
0.00%
ZGNX
8.62
-0.04
-0.46%
Home » Archive by Category

Xconomy

Seven Bridges Gets $45M, Begins Test Run for Cancer Genomics Tool

February 16, 2016 – 5:55 am

When President Obama announced the Precision Medicine Initiative last year ears perked up at Seven Bridges Genomics, one of a number of startups that helps researchers store, analyze, and interpret…

[[Click headline to continue reading.]]

Seven Bridges Gets $45M, Begins Test Run for Cancer Genomics Tool

February 16, 2016 – 5:55 am

When President Obama announced the Precision Medicine Initiative last year ears perked up at Seven Bridges Genomics, one of a number of startups that helps researchers store, analyze, and interpret…

[[Click headline to continue reading.]]

Biotech’s Recent Headlines, Reimagined In Verse and On Stage

February 16, 2016 – 4:30 am

  Dear Theranos, I noticed recently that you’re looking for a writer to work in your Palo Alto office. Please don’t tell my bosses at Xconomy, but I’m throwing my hat in the…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Grail, Juno, Amgen, Imprimis & More

February 12, 2016 – 7:54 am

The continuing market selloff has been brutal to biotech stocks. Barron’s reports that the SPDR S&P Biotech exchange traded fund and the iShares Nasdaq Biotechnology ETF are both in bear…

[[Click headline to continue reading.]]

Top Engineer Behind Google’s Rise Will Lead Grail In Cancer-Test Quest

February 10, 2016 – 7:53 am

Grail wants to develop a blood test that detects early stage cancer in seemingly healthy people, an ambitious and daunting proposition that I wrote about in detail last week. After a month in the…

[[Click headline to continue reading.]]

12 San Diego Life Sciences Startups to Watch in 2016

February 9, 2016 – 9:37 am

A whole new crop of life sciences startups are germinating in San Diego, which is good news for the regional cluster of established companies that are focused on innovation in biotechnology, medical…

[[Click headline to continue reading.]]

West Coast Bio Roundup: Tessier-Lavigne, Twist, Unity, Grail & More

February 5, 2016 – 12:27 pm

The biggest news on the West Coast this week came from Stanford University. The school has lured decorated neuroscientist Marc Tessier-Lavigne away from New York’s Rockefeller University to be…

[[Click headline to continue reading.]]

Improving Odds for Women in Tech? Take Notes from Biotech

February 4, 2016 – 6:59 am

At our entrepreneurial support organization, the Council for Entrepreneurial Development (CED), we often joke about adhering to the proper dress and catering code for our networking events: jeans and…

[[Click headline to continue reading.]]

Blood Simple? Grail’s Cancer Screening Quest Faces Tough Questions

February 4, 2016 – 4:30 am

[Corrected, 2/4/16, 2:05pm. See below.] Three weeks ago the world’s biggest genomic sequencing company, Illumina (NASDAQ: ILMN), unveiled a spinout called Grail to make blood tests that could…

[[Click headline to continue reading.]]

ViaCyte Reports on Stem Cell Diabetes Trial, Absorbs BetaLogics

February 3, 2016 – 10:00 pm

[Corrected 2/8/16, 11:20 am. See below.] In a deal that consolidates its position as a leader in developing a stem cell-derived treatment for diabetes, San Diego’s ViaCyte says today it is absorbing…

[[Click headline to continue reading.]]